Literature DB >> 24968705

Uveitis is associated with hypertension and atherosclerosis in patients with ankylosing spondylitis: a cross-sectional study.

Inger Jorid Berg1, Anne Grete Semb2, Désirée van der Heijde3, Tore K Kvien2, Jonny Hisdal4, Inge C Olsen2, Hanne Dagfinrud2, Sella A Provan2.   

Abstract

OBJECTIVES: Uveitis is the most common extra-articular manifestation in patients with ankylosing spondylitis (AS), but the literature describing AS patients with a history of uveitis is limited. The objective was to examine if a history of uveitis in patients with AS is associated with increased disease activity and functional impairment and to investigate whether uveitis is associated with an increased frequency of cardiovascular comorbidities, defined here as hypertension and atherosclerosis.
METHODS: Data were recorded cross-sectionally through patient interviews, blood samples, clinical examination, and questionnaires. Carotid plaques were identified by ultrasonography. AS disease activity and function were compared across categories of uveitis using ANCOVA analyses. Associations between uveitis and hypertension and atherosclerosis [atherosclerotic cardiovascular disease (CVD) and/or carotid plaque] were analyzed in multivariate logistic regression models.
RESULTS: Of 159 patients with AS (61.6% male, mean age 50.5 years), 84 (52.8%) had experienced one or more episodes of uveitis. AS disease activity was higher in patients with a history of uveitis, statistically significant for functional impairment [Bath AS Functional Index (BASFI)] [mean difference (95% CI)] lnBASFI = 0.2 (0.0-0.3), p = 0.05. Patients with uveitis had an increased odds ratio [OR (95% CI)] for hypertension [3.29 (1.29-8.41), p = 0.01] and atherosclerosis [2.57 (1.15-5.72), p = 0.02].
CONCLUSIONS: AS patients with a history of uveitis had non-significantly higher disease activity and significantly higher functional impairment. A history of uveitis was associated with hypertension as well as atherosclerosis. These results may be important in identifying AS patients with elevated risk of CVD but should be confirmed in longitudinal cohorts.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ankylosing spondylitis; Cardiovascular disease; Disease activity; Hypertension; Uveitis

Mesh:

Year:  2014        PMID: 24968705     DOI: 10.1016/j.semarthrit.2014.05.017

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  5 in total

1.  Evaluation of development of subclinical atherosclerosis in children with uveitis.

Authors:  Seçil Conkar; Suzan Güven Yılmaz; İlker Özgür Koska; Afig Berdeli; Sevgi Mir
Journal:  Clin Rheumatol       Date:  2017-07-10       Impact factor: 2.980

2.  Increased Risk of Acute Coronary Syndrome in Ankylosing Spondylitis Patients With Uveitis: A Population-Based Cohort Study.

Authors:  Kathy Ming Feng; Wu-Chien Chien; Yi-Hao Chen; Chien-An Sun; Chi-Hsiang Chung; Jiann-Torng Chen; Ching-Long Chen
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

Review 3.  Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic.

Authors:  Sakir Ahmed; Armen Yuri Gasparyan; Olena Zimba
Journal:  Rheumatol Int       Date:  2021-01-03       Impact factor: 3.580

4.  Uveitis as a Risk Factor for Developing Acute Myocardial Infarction in Ankylosing Spondylitis: A National Population-Based Longitudinal Cohort Study.

Authors:  Yi-Fen Lai; Ting-Yi Lin; Wu-Chien Chien; Chien-An Sun; Chi-Hsiang Chung; Yi-Hao Chen; Jiann-Torng Chen; Ching-Long Chen
Journal:  Front Immunol       Date:  2022-01-11       Impact factor: 7.561

5.  The Risk of Major Adverse Cardiovascular Events in Ankylosing Spondylitis Patients With a History of Acute Anterior Uveitis: A Nationwide, Population Based Cohort Study.

Authors:  Yi-Chiao Bai; Chin-Hsiu Liu; Pui-Ying Leong; Kuo-Lung Lai; Hsin-Hua Chen; James Cheng-Chung Wei
Journal:  Front Med (Lausanne)       Date:  2022-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.